Couverture de Touching Base

Touching Base

Touching Base

De : Genetic Engineering & Biotechnology News (GEN)
Écouter gratuitement

À propos de ce contenu audio

 Touching Base is the dynamic podcast series from the editors of GEN (Genetic Engineering & Biotechnology News). Each episode features a rotating cast of senior editors including John Sterling, Kevin Davies, Julianna LeMieux, Alex Philippidis, Uduak Thomas, Corinna Singleman and Fay Lin who delve into emerging stories, exchange ideas, and debate the latest trends in biotech. Additionally, they talk to some of the leading voices in the industry about what's now and next.

Hosted on Acast. See acast.com/privacy for more information.

Genetic Engineering & Biotechnology News (GEN) Politique et gouvernement Science
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • Women in Science, Robotics, Automation, SLAS, and Lilly Updates

      Women in Science, Robotics, Automation, SLAS, and Lilly Updates
      Feb 13 2026

      Women in Science Day (February 11) was the top of the list for discussion for GEN editors in this week’s podcast. They shared an anecdote on the history of the term “scientist”—hint it was coined for a woman. A modern scientist, Medra CEO Michelle Lee, discussed with GEN how the company is integrating robotics with AI for use in biological research. GEN attended SLAS this week and we got an update on the automation updates along with endeavors to increase the presence of women in biotech leadership. Finally, we get an update on Eli Lilly’s recent major deals followed by an update on Nektar Therapeutics clinical trial updates.

      Join GEN editors Corinna Singleman, PhD, Fay Lin, PhD, Uduak Thomas and Alex Philippidis for a discussion of the latest biotech and biopharma news.

      Listed below are links to the GEN stories referenced in this episode of Touching Base:

      Data Is a Robotics Problem, Medra CEO Says Physical AI Will Transform Biology

      By Fay Lin, PhD, GEN Edge, February 11, 2026


      Robots on the Red Line: A Video Update from SLAS 2026

      GEN, February 11, 2026


      SLAS Highlights: AI Labs, Small-Molecule SPR, Protein Interaction Assays, and Paper Labware

      By Uduak Thomas, GEN, February 11, 2026


      SLAS Highlights: Opening Keynote Spotlights Novel Target in Genomically Unstable Tumors

      By Uduak Thomas, GEN, February 11, 2026


      Opentrons Uses Nvidia Tech to Build Training Data That Powers Physical AI in the Lab

      By Uduak Thomas, GEN, February 9, 2026


      Beyond Obesity: Lilly Inks Up to $11.25B in Cancer, Immune System Deals

      By Alex Philippidis, GEN Edge, February 10, 2026


      Lilly, Seamless Ink Up-to-$1.12B Hearing Loss Collaboration

      By Alex Philippidis, GEN Edge, January 28, 2026


      Touching Base Podcast

      Hosted by Corinna Singleman, PhD

      Behind the Breakthroughs

      Hosted by Jonathan D. Grinstein, PhD

      Hosted on Acast. See acast.com/privacy for more information.
      Afficher plus Afficher moins
      33 min
    • Ex-CEO Behind Bars, 10x’s Clinical Ambitions, and Pharma’s AI Gambit

      Ex-CEO Behind Bars, 10x’s Clinical Ambitions, and Pharma’s AI Gambit
      Jan 30 2026

      We kick off the very first episode of 2026 with a major legal development. This week, the former CEO of CytoDyn was sentenced to 30 months in prison, more than a year after being convicted on multiple charges including four counts of securities fraud, two counts of wire fraud, and three counts of insider trading. Also, we examine recent investments in artificial intelligence by several major drugmakers, and where they are hoping the technology can make an impact. Then, the latest from 10x Genomics and its plans to expand into clinical diagnostics through new collaboration. And for some research news, a new study that explores how functional forms of amyloid can create stable memories.

      Join GEN editors Corinna Singleman, PhD, Alex Philippidis, Fay Lin, PhD, and Uduak Thomas for a discussion of the latest biotech and biopharma news.

      Listed below are links to the GEN stories referenced in this episode of Touching Base:

      Ex-CytoDyn CEO Sentenced to 30-Month Prison Term on Fraud, Insider Trading

      By Alex Philippidis, GEN, January 27, 2026


      Pharma Bets Big on AI Platforms with Flurry of New Year Deals

      By Fay Lin, PhD, GEN Edge, January 22, 2026


      JPM: Nvidia Launches AI Collaborations with Eli Lilly, Thermo Fisher

      By Alex Philippidis, GEN Edge, January 13, 2026


      Clinical Ambitions: 10x Expands Beyond Research with Trio of Collaborations

      By Alex Philippidis, GEN Edge, January 26, 2026


      Chai’s the Limit for AI Antibody Designer After $130M Series B Funding

      By Alex Philippidis, GEN Edge, December 16, 2025


      Lilly Expands AI Ties to Insilico, from Customer to Drug Discovery Partner

      By Alex Philippidis, GEN Edge, November 10, 2025


      How Brain May Deliberately Form Amyloids to Turn Experiences Into Memories

      GEN, January 26, 2026


      Touching Base Podcast

      Hosted by Corinna Singleman, PhD

      Behind the Breakthroughs

      Hosted by Jonathan D. Grinstein, PhD

      Hosted on Acast. See acast.com/privacy for more information.
      Afficher plus Afficher moins
      34 min
    • Editors’ Choice: Top Stories of 2025

      Editors’ Choice: Top Stories of 2025
      Dec 18 2025
      In the final episode of 2025, the GEN team came together to reflect on some of the stories over the last year that they each found impactful. Some of the stories were covered in GEN’s December issue, but our editors took the time to discuss some topics in a bit more depth during the podcast. The discussion began with an update on the progress of AI use in drug discovery. Cell and gene therapy was a big topic with the positive outcome for Baby KJ, while Sarepta dealt with a rollercoaster of a year with their DMD treatment, Elevidys. Research and biotech in Africa are growing and the discussion ranged from challenges to promise in research and development on the continent. This year’s NIH budget cuts and impacted institutions rounded out the conversation.Join GEN editors Corinna Singleman, PhD, Alex Philippidis, Fay Lin, Phd, Kevin Davies, Phd, John Sterling, and Uduak Thomas for a discussion of the latest biotech and biopharma news. Listed below are links to the GEN stories referenced in this episode of Touching Base: GEN Editors Reflect on Six of the Biggest Stories of the YearBy Alex Philippidis, Savannah Wiegel, Fay Lin, PhD, Kevin Davies, PhD, Uduak Thomas, and Julianna LeMieux, PhD, GEN, December 4, 2025StockWatch: Sarepta Says Deaths of Two Elevidys Patients Posted on FDA Database Unrelated to Treatment By Alex Philippidis, GEN Edge, August 10 StockWatch: As Prasad Exits FDA, Analysts See Benefit for Sarepta, CGT Stocks By Alex Philippidis, GEN Edge, August 3 FDA Probes Death of Brazilian Boy Linked to Sarepta’s Elevidys GEN Edge, July 27 Second DMD Patient Dies After Treatment with Sarepta Gene Therapy By Alex Philippidis, GEN Edge, June 15 DMD Patient Dies After Treatment with Sarepta Gene Therapy By Alex Philippidis, GEN Edge, March 18From The Editor in ChiefJohn Sterling, December Issue of GEN Gene Therapy in AfricaThe State of CRISPR & Genome Editing Summit, June 11, 2025TOP 50 NIH By Alex Philippidis, GEN, December 4, 2025 FDA Cell & Gene Therapy roundtable: Cell and Gene Therapy Leaders Tell FDA: “Believe in American Solutions” By Alex Philippidis, and Kevin Davies, PhD, GEN Edge, June 5, 2025Scientists in NYC Rally to Defend and Stand Up for ScienceBy Corinna Singleman, GEN, March 10, 2025Touching Base Podcast Hosted by Corinna Singleman, PhD Behind the Breakthroughs Hosted by Jonathan D. Grinstein, PhD Hosted on Acast. See acast.com/privacy for more information.
      Afficher plus Afficher moins
      41 min
    Aucun commentaire pour le moment